Article

In vitro characterization of three-dimensional scaffolds seeded with human bone marrow stromal cells for tissue engineered growth of bone: Mission impossible? A methodological approach

Department of Oral and Maxillofacial Surgery, George-Augusta-University, Göttingen, Germany.
Clinical Oral Implants Research (Impact Factor: 3.89). 05/2008; 19(4):379-86. DOI: 10.1111/j.1600-0501.2007.01483.x
Source: PubMed

ABSTRACT

The aim of the present report was to evaluate current methods of in vitro analysis of three-dimensional (3D) scaffolds seeded with human bone marrow stromal cells (hBMSCs) from six bone marrow aspirates for tissue engineered growth of bone.
A series of experiments was conducted to compare methods of cell expansion and to validate analysis of proliferation and differentiation of hBMSCs in long term cultures of up to 40 days in 3D scaffolds of calcium carbonate (CaCO(3)) and mineralized collagen. Proliferation within the seeded scaffolds was monitored using cell counting, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), neutral red (NR) and DNA fluorescence assays and compared with empty controls. Differentiation was assessed by means of ELISA for osteocalcin (OC) and real time PCR for OC and collagen I (Coll I).
The results showed that the scaffold differed in seeding efficacy (CaCO(3): 53.3%, min. Coll.: 83.3%). The precise identification of the number of cells in biomaterials by MTT, NR and DNA assays was problematic, as MTT and NR assay overestimated the number of cells, whereas DNA assay grossly underestimated the number of cells on the scaffolds. Monitoring of changes over time may be biased by unspecific material-dependent background activity that has to be taken into account. Identification of osteogenic differentiation is not reliable by identifying osteogenic markers such as OC in the supernatant but has to be done on the transcriptional level.
It is concluded that monitoring of in vitro procedures for the construction of biohybrid scaffolds requires more emphasis in order to make the cell based approach a reliable treatment option in tissue engineering.

0 Followers
 · 
3 Reads
  • Source
    • "Unfortunately, assessment of the specific activity of the cells inside the constructs remains difficult. Indirect techniques for the evaluation of cell differentiation by measuring the occurrence of osteogenic markers in the medium surrounding the seeded scaffolds are misleading, because many of these molecules that are produced by the cells will be deposited in the matrix inside the scaffolds (Materna et al., 2008). Transcription analysis using PCR can identify osteogenic differentiation (Goessler et al., 2006), but homogenisation of the scaffolds makes evaluation of cell numbers and analysis of cell distribution impossible. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present study was to test the hypothesis that a fibrin matrix enhances the osteogenic differentiation and expression of vascular endothelial growth factor (VEGF) by human bone marrow stromal cells (hBMSCs) seeded into mineralised scaffolds. Porous calcium carbonate scaffolds were droplet seeded with hBMSCs using a matrix containing 3 % fibrinogen and cultured for 3 weeks. Seeded scaffolds without the fibrin matrix served as controls. The scaffolds were evaluated, using undecalcified thick sections, for fluorescence staining for nuclei, osteocalcin (OC) and VEGF. The sections were systematically scanned using optical sectioning and three dimensional distributions of cells and positive staining indicating expression of OC and VEGF were reconstructed from the z-stacks. The fibrin matrix maintained a significantly higher level of cell numbers after 2 d and 1 week and delayed the onset of osteogenic differentiation while sustaining a significantly higher level of OC and VEGF expression after 2 and 3 weeks, starting from the periphery of the scaffolds. There was a decrease in cell density from the periphery to the centre of the scaffolds in both groups The percentage of cells expressing OC and VEGF was significantly different between the centre and the periphery of the scaffolds in the fibrin(+) group but not in the controls. It is concluded that the fibrin matrix used appears to be a useful adjunct for supporting and sustaining osteogenic and angiogenic activity of hBMSCs in tissue engineered constructs. This could help to improve their performance in a clinical setting.
    Preview · Article · Jun 2012 · European cells & materials
  • [Show abstract] [Hide abstract]
    ABSTRACT: As three-dimensional (3D) cell culture systems gain popularity in biomedical research, reliable assays for cell proliferation within 3D matrices become more important. Although many cell quantification techniques have been established for cells cultured on nondegradable plastic culture dishes and cells suspended in media, it is becoming increasingly clear that cell quantification after prolonged culture in 3D polymeric scaffolds imposes unique challenges because the added presence of polymeric materials may contribute to background signal via various mechanisms including autofluorescence, diffusion gradients, and sequestering effects. Thus, additional steps are required to ensure complete isolation of cells from the 3D scaffold. The diphenylamine assay isolates cellular DNA, degrades the polymeric matrix materials, and reacts with the DNA to yield a colorimetric response. Thus, we report here a practical modification of the diphenylamine assay and show that the assay quantifies cells in 3D polyester scaffolds reliably and reproducibly as long as the necessary amount of the acidic working reagent is present. Our study also demonstrates that the sensitivity of the assay can be optimized by controlling the dimensions of the sampling volume. Overall, the DPA assay offers an attractive solution for challenges associated with 3D cell quantification.
    No preview · Article · Jan 2009 · Journal of Biomedical Materials Research Part B Applied Biomaterials
  • [Show abstract] [Hide abstract]
    ABSTRACT: Orofacial rehabilitation after ablative surgery or trauma is one of the main objectives of oral and maxillofacial surgery. Many treatment strategies in this field thus fall into the realm of reconstructive surgery. A standard measure in the field of oral and maxillofacial reconstruction is the use of autogenous grafts for the replacement of tissue parts, which is associated with a significant increase in surgical effort and morbidity. The growing understanding of tissue healing and the achievements of biotechnology have raised hopes that defects of the jaw bones, articular cartilage, or oral mucosa can be repaired without the transfer of autogenous tissue and that custom made body parts can be cultivated from the patients own cells in the lab as a substitute for autogenous grafts.
    No preview · Article · Jan 2009
Show more